News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Ahmed Kotb: Bispecific Antibodies vs. CAR-T for Relapsed/Refractory Follicular Lymphoma
Jan 30, 2025, 17:32

Ahmed Kotb: Bispecific Antibodies vs. CAR-T for Relapsed/Refractory Follicular Lymphoma

Ahmed Kotb, Hematologist and Bone marrow transplanter at King Faisal Specialist Hospital International Holding Company, shared a post on X:

“Bispecific Antibodies vs. CAR-T for Relapsed/Refractory Follicular Lymphoma

BsAb

Off-the-shelf, outpatient, low toxicity

Possible indefinite treatment

CAR-T

Very high CR, long PFS, curative potential

Neurotoxicity risk,long wait time.”

Ahmed Kotb: Bispecific Antibodies vs. CAR-T for Relapsed/Refractory Follicular Lymphoma

Ahmed Kotb cancer OncoDaily Oncology
Special Coverage
Science
Aug 15, 2025, 08:43
Francesco Massari: Our First Translational Research from ARON-1α
Voices
Aug 15, 2025, 08:32
Yüksel Ürün: AI in Drug Discovery
Dialogues
Aug 15, 2025, 08:28
ONCOFFEE: Vera Megdanova on Oncology, Family, and the Challenges of Practicing Medicine in Bulgaria
Blog Posts
Aug 15, 2025, 08:03
Carmen Monge-Montero: Sometimes the Bravest Thing You Can Do is Ask for Help
Science
Aug 15, 2025, 07:31
Bishoy Morris Faltas: Paired Plus-Minus Sequencing for Accurate Dual-Strand DNA Analysis
Stories
Aug 15, 2025, 06:47
Oya Gilbert's Story Highlights Urgent Need to Protect NIH Research Funding - AACR
Science
Aug 15, 2025, 06:42
Denis Panizza: How Tight Can SBRT Prostate Margins Go?
Science
Aug 15, 2025, 06:33
Immune Youth in Old Age: Mayo Clinic Uncovers the Double-Edged Sword - E. Shyam P. Reddy
Voices
Aug 15, 2025, 06:32
Where AI Meets the Future of Cancer Research - NFCR
Insight
Aug 15, 2025, 06:24
Harpreet Singh: New Era for ADCs in HER-2 + Metastatic Breast Cancer
Science
Aug 15, 2025, 06:18
Ramy Sedhom Shares Study on Inpatient Immunotherapy Outcomes
Science
Aug 15, 2025, 06:11
Miguel Bronchud: Can Use of Aprepitant During Chemotherapy Improve TNBC Outcomes?